de Silva_1992_Lancet_339_1136

Reference

Title : Does pralidoxime affect outcome of management in acute organophosphorus poisoning? [see comments] - de Silva_1992_Lancet_339_1136
Author(s) : De Silva HJ , Wijewickrema R , Senanayake N
Ref : Lancet , 339 :1136 , 1992
Abstract :

Acute organophosphorus (OP) poisoning is usually treated with atropine plus cholinesterase reactivators such as oximes, but controlled trials to assess the efficacy of oximes in OP poisoning have not been done. A period when the acetyl cholinesterase reactivator pralidoxime chloride was not available in Sri Lanka gave us the opportunity to compare atropine alone for treatment of moderate to severe OP poisoning (21 patients) with atropine plus pralixodime (24 patients). Outcome, as assessed clinically, was similar in the two groups. These results cast doubt on the necessity of cholinesterase reactivators for treatment of acute OP poisoning.

PubMedSearch : de Silva_1992_Lancet_339_1136
PubMedID: 1349368

Related information

Citations formats

De Silva HJ, Wijewickrema R, Senanayake N (1992)
Does pralidoxime affect outcome of management in acute organophosphorus poisoning? [see comments]
Lancet 339 :1136

De Silva HJ, Wijewickrema R, Senanayake N (1992)
Lancet 339 :1136